Low incidence of alpha 1-antitrypsin deficiency among Filipinos with neonatal cholestatis

Journal of Paediatrics and Child Health

Volumn 42, Issue 11, 2006, Pages 694-697

  Tan, Josephine J ^a   Cutiongco Dela Paz, Eva Maria ^a   Avila, Jose Maria C ^b   Gregorio, Germana V ^a  

^a UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^b UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

Author keywords

Alpha 1 antitrypsin globule; Conjugated hyperbilirubinaemia; PAS stain

Indexed keywords

ALPHA 1 ANTITRYPSIN; REAGENT;

ALLELE; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; BILIRUBIN BLOOD LEVEL; CHOLESTASIS; CONTROLLED STUDY; DIAGNOSTIC KIT; FEMALE; FILIPINO; GENE FREQUENCY; GENETICS; GENOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; JAUNDICE; LIVER BIOPSY; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; NEWBORN; NEWBORN HEPATITIS; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL;

ALPHA 1-ANTITRYPSIN DEFICIENCY; CHOLESTASIS; FEMALE; HUMANS; INFANT; MALE; PHILIPPINES;

EID: 33750092222     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2006.00953.x     Document Type: Article

References (22)

1. Permutter D. Liver injury in alpha 1-antitrypsin: an aggregated protein induces mitochondrial injury. J. Clin. Invest. 2002; 110: 1579-83.
2. MacDonald JL, Johnson CE. Pathophysiology and treatment of alpha 1-antitrypsin deficiency. Am. J. Health Syst. Pharm. 1995; 52: 481-9.
3. Lomas DA, Mahadeva R. Alpha 1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. J. Clin. Invest. 2002; 110: 1585-90.
4. Massi G. Pathogenesis and pathology of liver disease associated with alpha 1-antitrypsin deficiency. Chest 1996; 110: 251S-5S.
5. Francavilla R, Castellaneta SP, Hadzic N et al. Prognosis of alpha 1-antitrypsin deficiency-related liver disease in the era of paediatric liver transplantation. J. Hepatol. 2000; 32: 986-92.
6. Lin L, Schmidt B, Teckman J, Perlmutter DH. A naturally occurring nonpolymerogenic mutant of alpha 1-antitrypsin characterized by prolonged retention in the endoplasmic reticulum. J. Biol. Chem. 2001; 276: 33893-8.
7. Primhak RA, Tanner MS. Alpha 1-antitrypsin deficiency. Arch. Dis. Child. 2001; 85: 2-5.
8. Massi G, Chiarelli C. Alpha 1-antitrypsin: molecular structure and the Pi system. Acta Paediatr. 1994; 393: 1S-4S.
9. World Health Organization. Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting. Bull. World Health Organ. 1997; 75: 397-414.
10. Francavilla R, Castellaneta SP, Hadzic N et al. Alpha 1-antitrypsin deficiency: a 29-year experience in 241 children. Hepatology 1998; 28: 639A.
11. Mowat AP. Alpha 1-antitrypsin deficiency (PiZZ): features of liver involvement in childhood. Acta Paediatr. 1994; 393: 13S-7S.
12. Sveger T. Liver disease in alpha 1-antitrypsin deficiency detected by screening of 200 000 infants. N. Engl. J. Med. 1976; 294: 1316-21.
13. de Serres FJ. Worldwide racial and ethnic distribution of alpha 1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. Chest 2002; 122: 1818-29.
14. Chongsrisawat V, Jantaradsamee P, Vivatvakin B, Pongpaew P, Poovorawan Y. Alpha 1-antitrypsin phenotype of children with liver diseases in Thailand. Asian Pac. J. Allergy Immunol. 1998; 18: 27-30.
15. Morse JO. Alpha 1-antitrypsin deficiency. Medical Progress. 1978; 299: 1045-8.
16. Deutsch J, Becker H, Auböck L. Histopathological features of liver disease in alpha 1-antitrypsin deficiency. Acta Pædiatr. 1994; 393: 8-12.
17. Aagenæs Ø, Matlary A, Elgjo K, Munthe E, Fagerhol M. Neonatal cholestasis in alpha 1-antitrypsin deficient children. Acta Paediatr. Scand. 1972; 61: 632-42.
18. Odièvre M, Martin J-P, Hadchouel M, Alagille D. Alpha 1-antitrypsin deficiency and liver disease in children: phenotypes, manifestations and prognosis. Pediatrics 1976; 57: 226-31.
19. Vecchio FM, Fabiano A, Orsini G, Ragasa D, Massi G. Alpha 1-antitrypsin MZ phenotype and cryptogenic chronic liver disease in adults. Digestion 1983; 27: 100-4.
20. Bell H, Schrumpf E, Fagerhol MK. Heterozygous alpha-1 antitrypsin deficiency in adults with chronic liver disease. Scand. J. Gastroenterol. 1990; 25: 788-92.
21. Carison JA, Eriksson S. Chronic 'cryptogenic' liver disease and malignant hepatoma in intermediate α-1 antitrypsin deficiency identified by a PiZ specific monoclonal antibody. Scand. J. Gastroenterol. 1985; 20: 835-42.
22. Graziadel IW, Joseph JJ, Wiesner RH, Therneau TM, Batts KP, Porayko MK. Increased risk of chronic liver failure in adults with heterozygous α-1 antitrypsin deficiency. Hepatology 1998; 28: 1058-63.